Trial Search

Current Search Criteria:

Intervention: Alphagan P
Found 17 matching trials

Pilocarpine and Brimonidine in Patients With Monofocal Lenses

EARLY_PHASE1

The current study aims to assess the use of pilocarpine and brimonidine to ...

Status

Unknown

Location

Massachusetts Eye and Ear

Start Date

2019-01-21

Trial ID

NCT03825081

Treatments Being Tested

Brimonidine, pilocarpine

Pre-Administration of Brimonidine in Intravitreal Anti-VEGF Therapy

NA

In this study, investigators will be examining the intraocular pressure low...

Status

Completed

Location

Multiple Locations

Start Date

2016-12-15

Trial ID

NCT03513172

Treatments Being Tested

topical brimonidine tartrate 0.15% (Alphagan® P; Allergan, Inc)

24-hour IOP-lowering Effect of Brimonidine 0.1%

PHASE4

This study will evaluate the efficacy and safety of brimonidine 0.1% three-...

Status

Completed

Location

Multiple Locations

Start Date

2006-12

Trial ID

NCT00457795

Treatments Being Tested

brimonidine 0.1% (Alphagan® P)

Effect of Prophylactic Aqueous Suppression on Hyperencapsulation of Ahmed Glaucoma Valves

PHASE4

After implantation of an Ahmed glaucoma valve in patients with glaucoma, hy...

Status

Unknown

Location

Credit Valley Eye Care

Start Date

2012-02

Trial ID

NCT01535768

Treatments Being Tested

Aqueous Suppressant Eye Drops

A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension

PHASE4

This study will evaluate the efficacy and safety of either bimatoprost 0.01...

Status

Completed

Location

Multiple Locations

Start Date

2012-01

Trial ID

NCT01525173

Treatments Being Tested

0.1% brimonidine tartrate ophthalmic solution0.01% bimatoprost ophthalmic solution0.2% hypromellose lubricant eye dropslatanoprost 0.005% ophthalmic solution

A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension

PHASE4

This study will evaluate 0.15% brimonidine tartrate in patients with primar...

Status

Completed

Location

Multiple Locations

Start Date

2010-07

Trial ID

NCT02003534

Treatments Being Tested

0.15% Brimonidine Tartrate

Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD)

PHASE1

The objective of this study is to establish whether patients with dry eye d...

Status

Terminated

Location

Illinois Eye and Ear Infirmary, University of Illinois

Start Date

2016-05

Trial ID

NCT02975557

Treatments Being Tested

Brimonidine 0.15%Brimonidine 0.075%Placebo

Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan

NA

The purpose of this study is to compare the additive effect on eye pressure...

Status

Completed

Location

Doheny Eye Institute

Start Date

2003-09

Trial ID

NCT00121147

Treatments Being Tested

TravatanAzoptAlphagan P

Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized, Multi-center Trial

PHASE4

Comparison of Efficacy and Ocular Surface Disease Assessment between BRIDIN...

Status

Unknown

Location

CHA University Bundang Medical Center

Start Date

2019-03-20

Trial ID

NCT04647461

Treatments Being Tested

Brimonidine Tartrate 1.5mgBrimonidine Tartrate 1.5mg

Brimonidine Tartrate for Pterygium Surgery

NA

Pterygium excision and conjunctival autograft surgery is commonly done to t...

Status

Unknown

Location

Multiple Locations

Start Date

2021-02

Trial ID

NCT04683159

Treatments Being Tested

Brimonidine Tartrate 0.15% Oph SolnBrimonidine Tartrate 0.025% Oph Soln
PreviousNext